122 related articles for article (PubMed ID: 20718940)
1. Meeting report from the Third Global Workshop on Melanoma.
Agarwala SS; di Pietro A; Flaherty KT; Garbe C; Grob JJ; Kashani-Sabet M; Kirkwood JM; Leachman S; Messina J; O'Day S; Ribas A; Sondak V
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-7. PubMed ID: 20718940
[No Abstract] [Full Text] [Related]
2. Advances in the treatment of late stage melanoma.
Walkington LA; Lorigan P; Danson SJ
BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638
[No Abstract] [Full Text] [Related]
3. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
4. Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.
Miller DM; Flaherty KT; Tsao H
Semin Cutan Med Surg; 2014 Jun; 33(2):60-7. PubMed ID: 25085663
[TBL] [Abstract][Full Text] [Related]
5. Melanoma--part 2: management.
Thirlwell C; Nathan P
BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
[No Abstract] [Full Text] [Related]
6. Clinical prognostic factors in adjuvant melanoma trial.
Nathanson L
J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
[No Abstract] [Full Text] [Related]
7. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
8. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment of metastatic melanoma: new approaches.
Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
11. Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.
Sondak VK; Smalley K
Pigment Cell Melanoma Res; 2009 Aug; 22(4):386-7. PubMed ID: 19624312
[No Abstract] [Full Text] [Related]
12. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
13. Node positive melanoma--a positive note?
Kelly J; Kerin MJ
Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
[No Abstract] [Full Text] [Related]
14. [Melanoma and search for therapeutic targets].
de la Fouchardière A
Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
[No Abstract] [Full Text] [Related]
15. Adjuvant IFN alpha2 therapy of melanoma.
Kirkwood JM
Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
[No Abstract] [Full Text] [Related]
16. [Guidelines for stage I to III melanoma].
Guillot B; Dalac S; Denis M; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
Bull Cancer; 2016 Sep; 103(9):743-52. PubMed ID: 27456259
[No Abstract] [Full Text] [Related]
17. Melanoma vaccines: developments over the past 10 years.
Klein O; Schmidt C; Knights A; Davis ID; Chen W; Cebon J
Expert Rev Vaccines; 2011 Jun; 10(6):853-73. PubMed ID: 21692705
[TBL] [Abstract][Full Text] [Related]
18. Industry makes strides in melanoma.
Garber K
Nat Biotechnol; 2010 Aug; 28(8):763-4. PubMed ID: 20697383
[No Abstract] [Full Text] [Related]
19. [Melanoma during pregnancy].
Pagès C; Misset JL; de Kerviler E; Bavoux F; Fernandez H; Viguier M
Ann Dermatol Venereol; 2012 Apr; 139(4):298-304; quiz 296-7, 306-7. PubMed ID: 22482486
[No Abstract] [Full Text] [Related]
20. Adjuvant interferon in the treatment of melanoma.
Middleton MR
Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
[No Abstract] [Full Text] [Related]
[Next] [New Search]